- Home
- AUPH vs SVM Comparison
AUPH vs SVM Comparison
Compare AUPH & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | SVM |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2014 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AUPH | SVM |
|---|---|---|
| Price | $16.96 | $11.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $17.25 | $10.50 |
| AVG Volume (30 Days) | 858.1K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-25-2026 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | $36.87 |
| Revenue Next Year | $15.74 | $35.34 |
| P/E Ratio | $32.00 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $10.34 | $5.47 |
| 52 Week High | $19.25 | $15.77 |
Technical Indicators
Market Signals| Indicator | AUPH | SVM |
|---|---|---|
| Relative Strength Index (RSI) | 61.94 | 50.19 |
| Support Level | $15.65 | $11.53 |
| Resistance Level | $17.80 | $13.31 |
| Average True Range (ATR) | 0.42 | 0.53 |
| MACD | 0.06 | -0.16 |
| Stochastic Oscillator | 85.50 | 42.09 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.